Yuanyuan Zhai

Beijing Key Laboratory For Immune Mediated Inflammatory Diseases
Beijing, 100000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Prognostic factor analysis of CD19 CAR-T therapy followed by hematopoietic stem cell transplantation in relapsed/refractory B-ALL.

Prognostic factor analysis of CD19 CAR-T therapy followed by hematopoietic stem cell transplantation in relapsed/refractory B-ALL.

Journal: Clinical and experimental medicine

Published: April 15, 2026

Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.

Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.

Journal: Molecular nutrition & food research

Published: November 21, 2022

Cardioprotection effect of Yiqi-Huoxue-Jiangzhuo formula in a chronic kidney disease mouse model associated with gut microbiota modulation and NLRP3 inflammasome inhibition.

Cardioprotection effect of Yiqi-Huoxue-Jiangzhuo formula in a chronic kidney disease mouse model associated with gut microbiota modulation and NLRP3 inflammasome inhibition.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 25, 2022

Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.

Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 15, 2022

Apigenin Alleviates Obesity-Associated Metabolic Syndrome by Regulating the Composition of the Gut Microbiome.

Apigenin Alleviates Obesity-Associated Metabolic Syndrome by Regulating the Composition of the Gut Microbiome.

Journal: Frontiers in microbiology

Published: November 03, 2021

Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.

Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 19, 2021

Intestinal Flora Mediates Antiobesity Effect of Rutin in High-Fat-Diet Mice.

Intestinal Flora Mediates Antiobesity Effect of Rutin in High-Fat-Diet Mice.

Journal: Molecular nutrition & food research

Published: October 16, 2021

Quercetin protects against palmitate-induced pancreatic β-cell apoptosis by restoring lysosomal function and autophagic flux.

Quercetin protects against palmitate-induced pancreatic β-cell apoptosis by restoring lysosomal function and autophagic flux.

Journal: The Journal of nutritional biochemistry

Published: July 02, 2021

Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease.

Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease.

Journal: Frontiers in medicine

Published: June 03, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026